Sur D, Havasi A, Lungulescu CV, Volovat SR, Burz C, Irimie A. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports [Internet]. 2022 May 13 [cited 2025 Jun. 1];95(3):251-9. Available from: https://medpharmareports.com/index.php/mpr/article/view/2120